Researcher
Ghislain Opdenakker
- Disciplines:Immunology
Affiliations
- Immunobiology (Rega Institute) (Lab)
Member
From1 Oct 2001 → Today - Molecular Immunology (Rega Institute) (Lab)
Member
From1 Oct 1999 → 30 Sep 2001
Projects
1 - 10 of 25
- Regulation and function of immune cell proteases in multiple sclerosis.From1 Jan 2021 → 31 Dec 2022Funding: Foundations, funds and other with scientific goal
- Intravital microscopy platform for infectious and inflammatory diseasesFrom1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- Study and selective targeting of monomeric and trimeric gelatinase B/ MMP-9From1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- Functional analysis of active alpha-2-macroglobulin/protease complexes and their potential applications in protease-driven diseasesFrom1 Oct 2019 → 30 Sep 2022Funding: FWO fellowships
- Immunomodulation of wound healingFrom1 Jun 2019 → 4 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Functional subset definition and molecular regulation of neutrophils and natural killer cells in infection and inflammation.From1 Oct 2017 → 30 Sep 2023Funding: BOF - projects, Fund Recuperation Fiscal Exemption
- Role of MMP-9 in systemic lupus erythematosus.From1 Oct 2016 → 30 Sep 2019Funding: FWO fellowships
- Post-translational modifications and multiple sclerosis: assessment of proteolysis and citrullination as disease-modifiers in animal models of neuroinflammation.From1 Jan 2016 → 31 Dec 2017Funding: Nonprofit institution or equivalents
- Novel posttranslational modifications of gelatinase B/matrix metalloproteinase-9From1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- Wound healing in diabetes with innate immune molecules and cellsFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
Publications
221 - 230 of 273
- GCP-2 expression by murine melanoma cells favours the incidence of metastases(2011)
Authors: LE Sima, V Negoita, I Gruia, Ghislain Opdenakker, SM Petrescu
Pages: 479 - 480 - Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection(2011)
Authors: Jo Van Damme, Sofie Struyf, Ghislain Opdenakker
Pages: 1001 - 7 - Modulation of Matrix Metalloproteinases and their tissue inhibitors in haemozoin-treated human microvascular endothelial cells(2011)
Authors: M Prato, S D'Alessandro, Philippe Van den Steen, Ghislain Opdenakker, P Aresel, D Taramelli, N Basilico
Pages: 310 - 310 - ALTERED RESOLUTION OF PERITONEAL INFLAMMATION IN MMP-9-DEFICIENT MICE(2011)
Authors: E Kolaczkowska, N Higashi, Y Nishimura, M Nakajima, T Irimura, Ghislain Opdenakker
Pages: 271 - 271 - Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis(2011)
Authors: Sofie Struyf, Ghislain Opdenakker, Karel Geboes, Jo Van Damme
Pages: 177 - 184 - Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis(2011)
Authors: Hannelien Verbeke, Sofie Struyf, Ghislain Opdenakker, Jo Van Damme
Pages: 54 - 62 - Gelatin degradation assay reveals MMP-9 inhibitors and function of O-glycosylated domain(2011)
Authors: Jennifer Vandooren, Nathalie Geurts, Philippe Van den Steen, Steven De Jonghe, Piet Herdewyn, Ghislain Opdenakker
Pages: 14 - 24 - Proangiogenic Gr-1(+) leukocytes recruited during hypoxia initiate angiogenesis in transplanted pancreatic islets through delivery of matrix metalloproteinase-9(2011)
Authors: G Christoffersson, E Vagesjo, Jennifer Vandooren, S Massena, Ghislain Opdenakker, M Phillipson
Pages: 21 - 21 - Inhibition of Enzymatic Degradation of Adhesive-Dentin Interfaces(2011)
Authors: Jan De Munck, Philippe Van den Steen, Kirsten Van Landuyt, André Poitevin, Ghislain Opdenakker, Bart Van Meerbeek
Pages: 350 - 352 - Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3(2011)
Authors: Sofie Struyf, Mieke Gouwy, Sam Noppen, Paul Proost, Ghislain Opdenakker, Jo Van Damme
Pages: 480 - 488